Eli Lilly
3,659 hedge funds and large institutions have $687B invested in Eli Lilly in 2024 Q3 according to their latest regulatory filings, with 246 funds opening new positions, 1,565 increasing their positions, 1,390 reducing their positions, and 113 closing their positions.
118% more first-time investments, than exits
New positions opened: 246 | Existing positions closed: 113
13% more repeat investments, than reductions
Existing positions increased: 1,565 | Existing positions reduced: 1,390
3% more funds holding
Funds holding: 3,565 → 3,659 (+94)
0.89% more ownership
Funds ownership: 82.22% → 83.11% (+0.89%)
3% less capital invested
Capital invested by funds: $707B → $687B (-$19.6B)
12% less call options, than puts
Call options by funds: $9.13B | Put options by funds: $10.4B
15% less funds holding in top 10
Funds holding in top 10: 555 → 474 (-81)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IAIM
International Assets Investment Management
Orlando,
Florida
|
+$11.2B |
| 2 |
PFA
Pathway Financial Advisers
Auburn,
Indiana
|
+$918M |
| 3 |
Morgan Stanley
New York
|
+$750M |
| 4 |
GQG Partners
Ft. Lauderdale,
Florida
|
+$722M |
| 5 |
IIC
Integrated Investment Consultants
Bloomfield Hills,
Michigan
|
+$622M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Primecap Management
Pasadena,
California
|
-$1.73B |
| 2 |
BlackRock
New York
|
-$1.36B |
| 3 |
Capital World Investors
Los Angeles,
California
|
-$1.31B |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$570M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$559M |
LLY Hedge Fund Activity: Q3 2024 in Review
3,659 of the 6,967 institutional investors tracked by Wall St. Rank reported a position in Eli Lilly (LLY) for Q3 2024, worth a combined $687B — down 2.8% from $707B a quarter earlier.
Buyers outnumbered sellers: 246 funds opened new LLY positions and 113 closed out — a net gain of 133 holders — while 1,565 added to existing stakes and 1,390 trimmed.
The largest buyer was International Assets Investment Management, adding an estimated $11.2B. The largest seller was Primecap Management, cutting an estimated $1.73B.
- 3,659 institutional investors held Eli Lilly (LLY) as of Q3 2024, up from 3,565 in Q2 2024.
- Funds reported $687B of Eli Lilly stock for Q3 2024, down 2.8% quarter-over-quarter.
- 246 funds opened new Eli Lilly positions in Q3 2024 and 113 closed out, a net change of +133 holders.
- The largest Eli Lilly buyer in Q3 2024 was International Assets Investment Management, an estimated $11.2B added.
- The largest Eli Lilly seller in Q3 2024 was Primecap Management, an estimated $1.73B sold.
Based on aggregated 13F filings for Q3 2024.